|
Volumn 115, Issue 3, 2001, Pages 609-611
|
Rituximab, a chimaeric anti-CD20 monoclonal antibody, in the treatment of hairy cell leukaemia
|
Author keywords
Anti CD 20 antibodies; Hairy cell leukaemia; Rituximab
|
Indexed keywords
ALPHA INTERFERON;
CD20 ANTIGEN;
CLADRIBINE;
RITUXIMAB;
ADULT;
AGED;
ARTICLE;
BONE MARROW BIOPSY;
CANCER RECURRENCE;
CANCER REGRESSION;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFECT;
FEMALE;
GASTROINTESTINAL HEMORRHAGE;
HAIRY CELL LEUKEMIA;
HUMAN;
MALE;
PATIENT COMPLIANCE;
PRIORITY JOURNAL;
SPLENECTOMY;
THROMBOCYTOPENIA;
TREATMENT OUTCOME;
ADULT;
AGED;
ANTIBODIES, MONOCLONAL;
ANTIGENS, CD20;
ANTINEOPLASTIC AGENTS;
FEMALE;
FOLLOW-UP STUDIES;
GASTROINTESTINAL HEMORRHAGE;
HUMANS;
LEUKEMIA, HAIRY CELL;
MALE;
MIDDLE AGED;
RECURRENCE;
THROMBOCYTOPENIA;
|
EID: 0035669026
PISSN: 00071048
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-2141.2001.03143.x Document Type: Article |
Times cited : (106)
|
References (12)
|